Characterization of fetal serum 5'-nucleotide phosphodiesterase: A novel function as a platelet aggregation inhibitor in fetal circulation

Thrombosis Research

Volumn 91, Issue 2, 1998, Pages 83-89

  Sakura, Harutake ^a   Nagashima, Sonoko ^a   Nakashima, Akira ^a   Maeda, Makoto ^a  

^a HAMAMATSU MEDICAL CENTER   (Japan)

Author keywords

5' Nucleotide phosphodiesterase; ADP; Platelet aggregation

Indexed keywords

ANTITHROMBOCYTIC AGENT; PHOSPHODIESTERASE;

ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; FETUS; FETUS BLOOD; FETUS CIRCULATION; HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; APYRASE; BINDING, COMPETITIVE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PLATELET AGGREGATION INHIBITORS;

EID: 0032527851     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00073-5     Document Type: Article

References (17)

1. Razzell WE. Phosphodiesterases. Method Enzymol 1963;6:236-58.
2. Kelly SJ, Dardinger DE, Butler LG. Hydrolysis of phosphonate esters catalyzed by 5′-nucleotide phosphodiesterase. Biochemistry 1975; 14:4983-8.
3. Tsou KC, Ledis S, McCoy MG. 5′-Nucleotide phosphodiesterase isoenzyme pattern in the serum of human hepatoma. Cancer Res 1973;33:2215-7.
4. Haugen HF, Skrede S. Nucleotide pyrophosphatase and phosphodiesterase I. Demonstration of activity in normal serum, and an increase in cholestatic liver disease. Scand J Gastroent 1976;11:121-7.
5. Haugen HF, Ritland S, Blomhoff JP, Solberg HE, Skrede S. Usefulness of serum nucleotide pyrophosphatase and phosphodiesterase I activities in classifying liver disease. Clin Chem 1981;27:1392-6.
6. Tsou KC, Lo KW, Rosato EF, Yuk A, Enterline H, Schwegman C. Evaluation of 5′-nucleotide phosphodiesterase isozyme-V as a predictor for liver metastasis in breast cancer patients. Cancer 1982;50:191-6.
7. Sakura H, Fujii T. Placental phosphodiesterase as a factor that inhibits ADP-induced platelet aggregation. In: Tomoda Y, editor. Placental and endometrial proteins. Utrecht-Tokyo: VSP; 1988. p. 433-7.
8. Machida Y, Nakanishi T. Utilization of bacterial xanthine oxidase for inorganic phosphorus determination. Agric Biol Chem 1982;46:807-8.
9. Born GVR, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178-95.
10. Lineweaver H, Burk D. The determination of enzyme dissociation constants. J Am Chem Soc 1934;56:658-66.
11. Haugen HF, Skrede S. Nucleotide pyrophosphatase and phosphodiesterase. I. Organ distribution and activity in body fluids. Clin Chem 1977;23:1531-7.
12. Iioka H, Hisanaga H, Akada S, Moriyama I, Ichijo M. The platelet aggregation inhibiting activity in human placenta: Study on the ADP degrading activity of human placental villi. Acta Obst Gynaec Jpn 1992;44:631-9.
13. Belli SI, Goding JW. Biochemical characterization of human PC-1, an enzyme possessing alkaline phosphodiesterase I and nucleotide pyrophosphatase activities. Eur J Biochem 1994; 226:433-43.
14. Belli SI, Van Uriel IR, Goding JW. Identification and characterization of a soluble form of the plasma cell membrane glycoprotein PC-I (5′-nucleotide phosphodiesterase). Eur J Biochem 1993;217:421-8.
15. Akkerman JW, Nieuwenhuis HK, Leautaud MEM, Gorter G, Sixma JJ. ATP-ADP compartmentation in storage pool deficient platelets: Correlation between granule-bound ADP and the bleeding time. Br J Haematol 1983;55:135-43.
16. Hutton RA, Dandona P, Chow FPR, Craft IL. Inhibition of platelet aggregation by placental extracts. Thromb Res 1980;17:465-71.
17. Corby DG, Zuck TF. Newborn platelet dysfunction: a storage pool and release defect. Thrombos Haemost 1976;36:200-7.